GLP-Complete: 3-Step System for Natural GLP-1 Pathway Support & Metabolic Balance
3-step daily system supporting GLP-1, gut health, and metabolism. · $119.99 or $101.99/mo
✓Code applied
Free shipping on subscriptions Free shipping over $75 · 30-day guarantee · Secure checkout
Trusted by 3.5M+ customers
A clear, honest look at what the research supports and what it doesn’t.
The short answer: Thinning hair in your 30s can have several causes. Low iron, thyroid shifts, stress, giving birth, stopping birth control, and gradual hormone-related changes at the follicle can all play a part, so a doctor or dermatologist is the right first stop. Folura™ Hair Density Softgel is a single-active supplement with 160 mg of Serevelle™ saw palmetto extract, the dose used in a 180-day placebo-controlled trial in which the active group showed greater improvement in hair counts and density than placebo.*
The evidence is real but modest: one small, manufacturer-sponsored trial of the ingredient, not of the finished product.
Your hair looks a little less full than it did a year ago. It may not be a missing vitamin.
You’re in your mid-to-late thirties. You catch your hair in a photo taken from above, or under the bright bathroom light, and it looks less full than you remember. The gummies did nothing. And a quiet question starts forming: what actually helps?
Before you try anything: if your part is widening quickly, you’re shedding in clumps, or your scalp is itchy or sore, see a dermatologist first. They can tell you what’s behind the change, and some causes need treatment rather than a supplement.
Many hair supplements focus on nutrients. When thinning is gradual and hormone-related, the change happens at the follicle, which is a different target than a nutrient gap.
Folura™ takes a different route. It’s a single-active softgel built around Serevelle™ saw palmetto extract at 160 mg, the dose used in a published, placebo-controlled trial, in a base of cold-pressed pumpkin seed oil. Rather than focusing on nutrients, it’s formulated to support hair at the follicle root, using an extract studied for its role in the DHT pathway.*
This guide explains what’s known about that approach, what the research found, and where the evidence stops, so you can decide with your doctor whether it makes sense for you.
One studied active at the researched dose, fully disclosed on the label, in a single daily softgel, for anyone who’d rather understand their supplement than trust a proprietary blend.
Folura™ Hair Density Softgel is a single-active hair-health supplement from Triquetra Health, formulated for women and men who want to support healthy hair density as their hair starts to change.*
This guide focuses on women in their 30s and 40s.
Each softgel delivers 160 mg of Serevelle™ saw palmetto extract, the dose used in published research, alongside 232 mg of cold-pressed pumpkin seed oil. That oil serves as the softgel’s oil base and a complementary ingredient. Together they’re formulated to support healthy hair density and the natural hair growth cycle.*
The softgel itself is made from pea starch, so it’s vegan, and the product is soy-free, gluten-free, and GMO-free. Each bottle holds 30 softgels, a one-month supply.
Serevelle™ was studied in a 180-day randomized, double-blind, placebo-controlled trial of 60 adults, 30 men and 30 women (Ablon, 2026). The extract is a proprietary bioactive free fatty acid extract of Serenoa repens, produced by supercritical CO₂ extraction without cosolvents. Folura™ is GMP-manufactured and third-party tested.
What sets it apart for a label-reader is simple. One disclosed active at the studied dose. One softgel a day. A label you can check against the actual research.
There’s a specific feeling that comes with noticing this in your thirties: already? Part surprise at confronting something you’d filed under “later,” part frustration at not knowing what actually helps.
You’ve probably got a small graveyard of attempts. Half-used gummies in a drawer. A rosemary oil. Maybe a collagen powder. None of them seemed to change anything. You looked at the multi-capsule “systems” and knew, honestly, you wouldn’t keep up with them. Underneath all of it sits a reasonable instinct: you’d rather start a considered routine now than keep guessing.
That instinct is sound. The only thing worth reframing is where to act. Gradual, hormone-related thinning originates at the follicle, so the follicle is where a targeted approach makes sense. Not a promise about the future. Just a way to support your hair at the root.*
Most of what’s marketed to younger women for hair falls into a few buckets, and each addresses a different pathway than a follicle-level, hormone-related process.
These are easy and feel low-risk, which is exactly their appeal. Here’s the catch: biotin deficiency is rare (NIH Office of Dietary Supplements, 2022), and a 2024 review of the literature found no study demonstrating that biotin supplementation benefits hair growth in healthy individuals (Yelich et al., 2024). A 2026 systematic review of 10 studies reached the same conclusion for people without a documented deficiency (Moltó-Balado et al., 2026).
If your hair is thinning despite a decent diet, a nutrient-focused product may not reach a follicle-level process. Nutrition still matters for overall hair health. It just may not be the lever here.
One practical footnote most brands skip: high-dose biotin can interfere with common lab immunoassays, including thyroid and cardiac tests (Yelich et al., 2024), which is why the FDA has warned about it (U.S. Food and Drug Administration, 2022). Mention it to your doctor before bloodwork.
Multi-capsule hair formulas often tell a comprehensive story, and some have earned real trust. For a label-reader the problem is verification: some place saw palmetto inside a proprietary blend that doesn’t disclose the individual amount, so you can’t tell whether the most relevant active is present at a dose any study used. A multi-capsule routine can also be harder to keep up across the months that matter most.
These deserve more credit than they usually get from brands like ours. So, the straight version. Panahi et al. (2015) randomized 100 men to rosemary oil or a 2% topical hair-regrowth medication for six months. Hair counts didn’t change significantly at three months, but both groups showed significant increases by six months, with no significant difference between them.
That’s a real finding. Two qualifications: there was no placebo group, so we can’t tell how much of the gain either product caused, and it was a single study in men. Rosemary oil is applied to the scalp and is thought to work locally rather than through androgen conversion, so it’s a different route from Folura™, not a competing version of it. The two aren’t mutually exclusive.
None of this makes those products bad. It’s a mismatch of mechanism to cause. If what’s changing for you is follicular and hormonal, the useful question becomes: what supports the follicle where the change is happening?
Follicles sensitive to androgens can gradually miniaturize: they shrink, so hair grows in finer and cycles out sooner (Ntshingila et al., 2023). In women, androgens are one factor among several, and their role is less clear-cut than in men (Ramos & Miot, 2015). That’s why a follicle-level approach is a different target than a nutrient-only one.
Here’s how each ingredient in Folura™ fits the follicle story.
In laboratory testing on human dermal papilla cells (a type of hair follicle cell), the Serevelle™ extract, tested under its earlier name USPlus® DERM, inhibited 5-alpha-reductase, the enzyme that converts testosterone to DHT. It did so more potently than a standard commercial saw palmetto extract and a USP-standardized saw palmetto extract. In that test, the amount needed for half-maximal inhibition was about 75 times lower than for the standard extract and about 23 times lower than for the USP extract (Broadley et al., 2026).*
Being clear about what that means: lab findings describe a mechanism. They don’t predict a person’s results, and the human trials measured hair counts and density, not DHT.
Beyond the DHT pathway, the extract has been studied in the anagen (active growth) phase. In scalp follicles grown in the lab, it helped more follicles stay in the growth phase (Broadley et al., 2026). That work is preclinical, in follicles from male donors cultured without testosterone.
Cold-pressed pumpkin seed oil (232 mg) is the oil the extract is delivered in. It naturally contains phytosterols, plant compounds examined in laboratory research for their interaction with 5-alpha-reductase (Hosking et al., 2019). Human hair research on pumpkin seed oil is limited (see below), so we treat it as a complementary ingredient, not a second clinically dosed active.
The honest version, in one breath: saw palmetto’s hair research centers on the DHT pathway, the clinical outcomes below come from a real but small trial, and individual responses vary. What you’re choosing is a studied form at a studied dose.
Mechanism matters because of what it can mean in an ordinary week.
Over three to six months, the goal is supporting healthy hair density so your hair looks fuller.* Gradual and cumulative. Not overnight, and not guaranteed for everyone.
So much of the stress here is the not-knowing, the constant mirror-checking. Trading anxious monitoring for one daily habit you can explain to yourself is its own kind of benefit.
You noticed something and did something considered about it. That shift, from watching to acting, can be its own kind of relief.
This reader deserves straight talk. No supplement should be sold as a way to halt or reverse changes in your hair, and Folura™ isn’t. What a follicle-root approach can do is support healthy hair density and the natural hair growth cycle with consistent daily use.*
In the published trial, measurable change showed up at the Day 90 assessment, and the gap versus placebo kept widening through Day 180. Set the timeline honestly, then track it.

Folura™ is built on Serevelle™, which has published, placebo-controlled human data at the same extract and dose used in Folura™. Here’s the straight accounting.
A six-month, randomized, double-blind, placebo-controlled study of daily oral Serevelle™ (n = 40 active) versus placebo (n = 20) in healthy adults aged 25 to 65 with self-perceived thinning hair, 30 men and 30 women. At Day 180, active treatment outperformed placebo on the primary endpoints:

You’ll often see these quoted as “+283% / +414% / +306% greater improvement.” Those relative figures do come from the paper. They’re also amplified by the fact that the placebo group declined over six months, so “306% greater” reads bigger than the underlying change warrants. The takeaway that holds up is direction and significance: the active group gained hair on measures where the placebo group lost it.
The 90-day interim (Ablon, 2025) documented significant gains in terminal and total hair counts versus placebo, plus a significant gain in vellus hairs at the front of the scalp. The 180-day paper then reported that the net treatment effect versus placebo was about 40% larger at Day 180 than at Day 90 (Ablon, 2026).* That’s the real reason consistency across the full window matters.
Pumpkin seed oil has been tested in one 24-week RCT, and it needs a caveat rather than a flourish. In 76 men with hereditary-pattern thinning, blinded investigators rated 44.1% of the active group as improved versus 7.7% on placebo (Cho et al., 2014).
Three qualifications: the study product also contained other plant ingredients, so the result can’t be credited to pumpkin seed oil alone (Hosking et al., 2019); it used 400 mg a day, and Folura™ contains 232 mg, about 58% of that amount; and it enrolled men only. The trial was supported by a company grant (Dreamplus Co., Ltd.).
This is a single, small trial sponsored by the ingredient manufacturer, Valensa International, and it studied the ingredient, not the finished Folura™ product. There’s no data beyond 180 days yet. The published subgroup analyses covered men and menopausal women, so there’s no placebo-controlled breakout for premenopausal women in their 30s and 40s. The average participant was 50, and the one small analysis that included premenopausal women (15 women) had no placebo comparison. That’s a real gap for this audience. No treatment-related adverse events were reported.
Folura™ is made with a clinically studied ingredient. It is not “clinically proven.” A modest but real evidence base, described accurately.
If you read labels, here are the trade-offs worth understanding.
For dose transparency, probably your top criterion: one disclosed active at the 160 mg studied dose, no proprietary blend. Compare that with multi-ingredient formulas where the saw palmetto amount sits inside an undisclosed blend, or standalone saw palmetto that discloses a dose but isn’t necessarily the form used in the hair research.
For the right form: Serevelle™ is the concentrated, characterized free fatty acid extract used in the hair trials, not generic dried-berry powder. Form matters because saw palmetto products vary widely in what they contain. In a blinded analysis of 28 commercial saw palmetto products (Chughtai et al., 2023), none of the berry powders or powdered extracts reached the 80% total fatty acid level that USP sets for lipid extracts, and only one of the 28 met the full USP criteria for a standardized lipidosterolic extract. For balance: the lead author discloses consulting for the same ingredient manufacturer.
For a follicle-root mechanism: an extract studied in the DHT pathway, versus biotin and gummies, which work through a nutritional pathway. These aren’t mutually exclusive. If you want to combine approaches, do it with a clinician’s input.
For staying consistent: one softgel daily, versus multi-capsule routines.
For verification: third-party testing and GMP manufacturing, in a category where adulterated saw palmetto extracts have been documented in the ingredient supply chain (Gafner & Baggett, 2018).
The claim isn’t that other products are bad. It’s that Folura™ holds a specific, defensible position: a single disclosed active, at the studied dose, in the studied form, that you can check against the research yourself.

Several things besides hormones. Common triggers of diffuse shedding include giving birth, stopping birth-control pills, a very stressful event, a high fever or illness, and significant weight loss, and the shedding usually shows up a few months after the trigger (American Academy of Dermatology, n.d.). Low iron and thyroid changes can also be involved (Hughes et al., 2024). A DHT-pathway supplement won’t address these, so start with your doctor.
Gummies and biotin supply nutrients. They don’t address a follicle-level, hormonal process. Folura™ works at the follicle instead, using Serevelle™ saw palmetto extract at 160 mg, an extract studied in the DHT pathway and shown in a placebo-controlled trial to support hair counts and density.* One disclosed active at the studied dose, a different mechanism.
Partly. Half of the 60 trial participants were women, and adults aged 25 to 65 could enroll, but the average participant was 50 (Ablon, 2026). The published placebo-controlled subgroup analyses covered men and menopausal women. There’s no placebo-controlled breakout yet for premenopausal women in their 30s and 40s, so results in your age group haven’t been measured separately. If you’re in perimenopause or menopause, our companion guide on menopause and hair covers that stage: [MENOPAUSE PILLAR URL].
Yes, and please do. The primary trial is Ablon (2026) in the Journal of Cosmetic Dermatology, with a 90-day interim published in 2025. Both are linked in the references below. The Folura™ label lists Serevelle™ at 160 mg, the dose used in that research, right on the label, with no proprietary blend hiding the amount. Match the label to the paper. That’s exactly the verification a proprietary blend makes impossible.
Plan for a gradual timeline. In the trial, significant changes in hair count were documented at the Day 90 assessment, and the gap versus placebo was larger at Day 180, so consistency across the full window matters.* Visible fullness builds over three to six months as follicles cycle. Individual responses vary, and some women will see less than the trial averages. Take a monthly scalp photo in the same lighting and at the same angle so you’re tracking it honestly.
Saw palmetto may interact with estrogen-containing medications, including birth control pills and hormone therapy, and could make them less effective, according to the MSD Manual (Shane-McWhorter, 2025). If you use either, talk to your provider before starting. It’s also cautioned alongside blood thinners and antiplatelet medications such as warfarin or clopidogrel, and it shouldn’t be used if you’re pregnant, nursing, or trying to conceive.
Saw palmetto is generally well tolerated in research, with mild, infrequent side effects such as digestive upset or headache (National Center for Complementary and Integrative Health, 2025). No treatment-related adverse events were reported in the published Serevelle™ studies (Ablon, 2025, 2026). Your provider is the right person to weigh your situation.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary. Consult your healthcare provider before starting any new supplement regimen.
By now the picture should be clearer. If your gummies haven’t helped, they may simply have been built for a nutritional problem rather than a follicular one, and a follicle-root approach is a different target.
Folura™ offers one studied active at the researched dose, in the studied form, in a single daily softgel, with a label you can verify against published human data. Individual results vary, and the evidence is a real but modest single trial sponsored by the ingredient manufacturer. We’d rather tell you that now than have you feel misled later.
If you’d like to compare the label with the research yourself, the full ingredient list and directions are on the product page.
See the Folura™ label and product details
A concentrated Serenoa repens extract, produced by supercritical CO₂ extraction without cosolvents. Same extract and dose used in the Ablon 2025 and 2026 trials, where the 160 mg extract delivered 105 mg of the bioactive fatty acid complex. The trials used a gelatin softgel; Folura™ uses a vegan pea-starch softgel.
Serves as the oil base of the softgel. The amount here is complementary and is not intended to match the dose used in published research. Pumpkin seed oil’s relevance to hair rests on one 24-week RCT in men that used a multi-ingredient product containing 400 mg/day (Cho et al., 2014), with the composition caveat noted above.
Pea starch, glycerin, carrageenan, disodium phosphate, and purified water, which make up the vegan softgel shell. Folura™ is vegan, soy-free, gluten-free, and GMO-free.
One softgel daily, as directed on the label. Each bottle holds 30 softgels, a one-month supply. Both ingredients are listed with their amounts on the Supplement Facts panel, with no blend hiding either dose.
Saw palmetto is generally well tolerated, with mild and infrequent adverse effects, and has been used safely in research studies for up to three years (National Center for Complementary and Integrative Health, 2025). Because saw palmetto may have hormonal effects, review it with your provider before starting, particularly if you use estrogen-containing medications such as birth control pills or hormone therapy (saw palmetto may reduce their effectiveness), take anticoagulant or antiplatelet medication, or are pregnant, nursing, or trying to conceive (Shane-McWhorter, 2025). Formulated for adults 18 and over.
Worth considering when a woman in her 30s or 40s wants to support healthy hair density at the follicle rather than reach for another gummy.* When she values full dose transparency and a single disclosed active she can verify against the research. When she’s skeptical of proprietary blends and wants a routine she’ll actually stick with. And when she wants the studied free fatty acid form, not generic berry powder.
Probably not the right fit when thinning is clearly linked to a diagnosed medical condition, a medication, or a nutritional deficiency better addressed with a clinician. Or when she prefers a topical-only routine, or is already on a provider-directed protocol. Or when she uses estrogen-containing medications or blood thinners and hasn’t cleared it with her provider. Or during pregnancy, nursing, and active efforts to conceive.
One more caveat that belongs specifically to you. Women in their 30s and 40s commonly have non-hormonal causes of shedding, too (Cleveland Clinic, 2022; Hughes et al., 2024). Low ferritin. Thyroid shifts. A stressful event a few months back. Stopping birth-control pills. Giving birth (American Academy of Dermatology, n.d.). Each of those produces diffuse shedding that a DHT-pathway supplement won’t address. Asking your doctor about iron and thyroid testing is a sensible first step before any supplement (Hughes et al., 2024).
The honest bottom line: Folura™ is a transparent, single-active option with real but modest clinical support and a mechanism aimed at gradual, hormone-related changes in hair density. For the right person, and with a doctor’s input, it’s a reasonable, evidence-informed option. It’s not a shortcut, and it’s not a substitute for finding out what’s behind the change.
Ablon, G. (2025). The safety and efficacy of a proprietary bioactive fatty acids extract from saw palmetto (Serenoa repens) for promoting hair growth and reducing hair loss in adults with self-perceived thinning hair: 90-day results. Journal of Cosmetic Dermatology, 24(12), e70585. https://doi.org/10.1111/jocd.70585
Ablon, G. (2026). The safety and efficacy of a novel saw palmetto (Serenoa repens) extract for promoting hair growth in adults with self-perceived thinning hair: 180-day results. Journal of Cosmetic Dermatology, 25(2), e70717. https://doi.org/10.1111/jocd.70717
American Academy of Dermatology. (n.d.). Do you have hair loss or hair shedding? https://www.aad.org/public/diseases/hair-loss/insider/shedding
Broadley, D., Le Riche, A., Guénin, S., Jimenez, F., Vinocur, L., Edelkamp, J., & Bertolini, M. (2026). A proprietary lipidosterolic extract of Serenoa repens promotes hair growth through mechanisms that extend beyond 5-alpha reductase inhibition: Insights from human hair follicle organ culture. International Journal of Cosmetic Science, 48(2), 352-366. https://doi.org/10.1111/ics.70035
Cho, Y. H., Lee, S. Y., Jeong, D. W., Choi, E. J., Kim, Y. J., Lee, J. G., Yi, Y. H., & Cha, H. S. (2014). Effect of pumpkin seed oil on hair growth in men with androgenetic alopecia: A randomized, double-blind, placebo-controlled trial. Evidence-Based Complementary and Alternative Medicine, 2014, 549721. https://doi.org/10.1155/2014/549721
Chughtai, B., Bhojani, N., Zorn, K. C., & Elterman, D. (2023). Variability of commercial saw palmetto-based supplements in the United States. JU Open Plus, 1(8), e00037. https://doi.org/10.1097/JU9.0000000000000040
Cleveland Clinic. (2022, December 1). Telogen effluvium. https://my.clevelandclinic.org/health/diseases/24486-telogen-effluvium
Gafner, S., & Baggett, S. (2018). Adulteration of saw palmetto (Serenoa repens) (Version 3). Botanical Adulterants Prevention Bulletin. ABC-AHP-NCNPR Botanical Adulterants Prevention Program. https://umb.herbalgram.org/media/ceqeziln/bap-babs-sawpalmetto-cc-102018-v3.pdf
Hosking, A.-M., Juhasz, M., & Atanaskova Mesinkovska, N. (2019). Complementary and alternative treatments for alopecia: A comprehensive review. Skin Appendage Disorders, 5(2), 72-89. https://doi.org/10.1159/000492035
Hughes, E. C., Syed, H. A., & Saleh, D. (2024). Telogen effluvium. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK430848/
Moltó-Balado, P., Simeó-Monzo, A., & del Barrio-Gonzalez, A. (2026). Effectiveness of biotin supplementation for hair growth in patients with alopecia: A systematic review. Dermato, 6(2), 17. https://doi.org/10.3390/dermato6020017
National Center for Complementary and Integrative Health. (2025, April). Saw palmetto. U.S. Department of Health and Human Services. https://www.nccih.nih.gov/health/saw-palmetto
National Institutes of Health, Office of Dietary Supplements. (2022, January 10). Biotin: Fact sheet for health professionals. U.S. Department of Health and Human Services. https://ods.od.nih.gov/factsheets/Biotin-HealthProfessional/
Ntshingila, S., Oputu, O., Arowolo, A. T., & Khumalo, N. P. (2023). Androgenetic alopecia: An update. JAAD International, 13, 150-158. https://doi.org/10.1016/j.jdin.2023.07.005
Panahi, Y., Taghizadeh, M., Marzony, E. T., & Sahebkar, A. (2015). Rosemary oil vs minoxidil 2% for the treatment of androgenetic alopecia: A randomized comparative trial. Skinmed, 13(1), 15-21. https://pubmed.ncbi.nlm.nih.gov/25842469/
Ramos, P. M., & Miot, H. A. (2015). Female pattern hair loss: A clinical and pathophysiological review. Anais Brasileiros de Dermatologia, 90(4), 529-543. https://doi.org/10.1590/abd1806-4841.20153370
Shane-McWhorter, L. (2025, July). Saw palmetto. In MSD Manual Consumer Version. https://www.msdmanuals.com/home/special-subjects/dietary-supplements-and-vitamins/saw-palmetto
U.S. Food and Drug Administration. (2022, June 21). Biotin interference with troponin lab tests: Assays subject to biotin interference. https://www.fda.gov/medical-devices/in-vitro-diagnostics/biotin-interference-troponin-lab-tests-assays-subject-biotin-interference
Yelich, A., Jenkins, H., Holt, S., & Miller, R. (2024). Biotin for hair loss: Teasing out the evidence. The Journal of Clinical and Aesthetic Dermatology, 17(8), 56-61. https://pmc.ncbi.nlm.nih.gov/articles/PMC11324195/
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary. Consult your healthcare provider before starting any new supplement regimen.